Crocs, Inc. v. Effervescent, Inc

District Court, D. Colorado·Decided September 7, 2022·No. 1:06-cv-00605·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Chief Judge Philip A. Brimmer

Civil Action No. 06-cv-00605-PAB-MDB

CROCS, INC.,

Plaintiff,

v.

DOUBLE DIAMOND DISTRIBUTION, LTD., and U.S.A. DAWGS, INC.,

Defendants.

ORDER

This matter is before the Court on the Individual Defendants’ Motion for Attorney’s Fees [Docket No. 1081]. Defendants Double Diamond Distribution, Ltd. (“Double Diamond”) and U.S.A. Dawgs, Inc. (“U.S.A. Dawgs” and, collectively with Double Diamond, “Dawgs”) responded, Docket No. 1093, and the Individual Defendants replied. Docket No. 1096.1 I. BACKGROUND The Court assumes familiarity with this dispute and will not discuss the procedural history or background facts beyond what is necessary to resolve this motion. Additional background facts can be found in previous orders and recommendations.

1 With the exception of George Boedecker, who settled separately, Docket No. 1081 at 2 n.2, the “Individual Defendants” are the eighteen current or former directors of plaintiff Crocs, Inc. (“Crocs”) who Dawgs sued in Case No. 16-cv-02004, which the Court consolidated with this action on January 27, 2017. See Docket No. 426. All cites to docket entries without a case number refer to filings in Case No. 06-cv-00605. See, e.g., Docket Nos. 673, 897.2 On May 31, 2016, Dawgs asserted patent, false-advertising, antitrust, and state- law tort counterclaims against Crocs. See generally Docket No. 209. Shortly thereafter, Dawgs filed Case No. 16-cv-02004 against the Individual Defendants. Dawgs’s claims

against the Individual Defendants were almost verbatim copies of its counterclaims against Crocs. Compare Case No. 16-cv-02004, Docket No. 1 with Case No. 06-cv- 00605, Docket No. 487. Sixteen of the eighteen defendants moved to dismiss. Case No. 16-cv-02004, Docket No. 31. Before ruling on that motion, the Court stayed discovery in Case No. 16-cv-02004 pending the outcome of the motion to dismiss. Case No. 16-cv-02004, Docket No. 63. The Court consolidated the two cases, Case No. 16-cv-02004, Docket No. 66; Case No. 06-cv-00605, Docket No. 426, and granted in part and denied in part the Individual Defendants’ motion to dismiss. Docket No. 673. The Court dismissed all of Dawgs’s claims except for the Lanham Act claim, which the Court found Dawgs plausibly alleged. Id. The parties proceeded to discovery, which

was interrupted by an administrative closure related to U.S.A. Dawgs’s bankruptcy between March 19, 2018 and July 14, 2020. Docket Nos. 821, 842. On March 11, 2021, the Court dismissed Raymond Croghan, Ronald Frasch, Prakash Melwani, Michael Marks, Thomas Smach, Andrew Rees, Gregg Ribatt, and Andrew Reddyhoff for lack of personal jurisdiction. Docket No. 928. On March 23, 2021, as mentioned previously, the Court dismissed Mr. Boedecker pursuant to a

2 The remaining claims in Case No. 06-cv-00605-PAB-MBD were set for a five- day jury trial to begin July 11, 2022. Docket No. 1104. On July 9, 2022, the parties notified the Court that Dawgs accepted Crocs’s Federal Rule of Civil Procedure 68 offers of judgment. Docket Nos. 1177, 1178, 1179. The Court vacated the trial, Docket No. 1180, and entered final judgment. Docket No. 1182. stipulation of dismissal. Docket No. 931. On September 14, 2021, the Court granted the motion for summary judgment filed by Ronald Snyder, Lyndon Hanson, Daniel Hart, Sara Hoverstock, Jeffrey Lasher, Donald Lococo, Michael Margolis, John P. McCarvel, and Erik Rebich, dismissing Dawgs’s Lanham Act claim against those defendants.

Docket No. 1071 at 2–15. On July 1, 2022, the Court denied Dawgs’s motion for reconsideration of that order. Docket No. 1165. The Individual Defendants argue that they are entitled to attorney’s fees because Dawgs’s suit “never had an objective basis in law or fact, was filed for an improper purpose, and was pursued in an unreasonable and vexatious manner.” Docket No. 1081 at 5–6. Dawgs opposes the motion. Docket No. 1093. Dawgs argues that the motion is premature because final judgment has not entered and because the case is not “exceptional” under the Lanham Act. Id. at 3. II. LEGAL STANDARD “‘Our basic point of reference’ when considering the award of attorney’s fees is

the bedrock principle known as the ‘American Rule’: Each litigant pays his own attorney’s fees, win or lose, unless a statute or contract provides otherwise.” Hardt v. Reliance Standard Life Ins. Co., 560 U.S. 242, 252–53 (2010). The Lanham Act and Patent Act provide statutory bases for attorney’s fees and provide that the “court in exceptional cases may award reasonable attorney fees to the prevailing party.” See 15 U.S.C. § 1117(a); 35 U.S.C. § 285. The leading case on attorney’s fees in § 285 Patent Act cases is Octane Fitness, LLC v. ICON Health & Fitness, Inc., 572 U.S. 545, 554 (2014), whose standards the Tenth Circuit has extended to § 1117(a) Lanham Act cases. See Derma Pen, LLC v. 4EverYoung Ltd., 999 F.3d 1240, 1246 (10th Cir. 2021) (“Based on the above, we conclude that the Octane standard applies to fee-shifting disputes under the Lanham Act.”). The Court may shift attorney’s fees under § 285 in a case that stands out from others with respect to the substantive strength of a party’s litigating position (considering both the governing law and the facts of the case) or the unreasonable manner in which the case was litigated. District courts may determine whether a case is “exceptional” in the case- by-case exercise of their discretion, considering the totality of the circumstances.

Octane, 572 U.S. at 554 (footnote omitted). The Court should take into account equitable considerations, such as “frivolousness, motivation, objective unreasonableness (both in the factual and legal components of the case) and the need in particular circumstances to advance considerations of compensation and deterrence.” Id. at 554 n.6 (citation omitted). The Tenth Circuit has explained that “a case may be deemed exceptional because of “(1) its lack of any foundation, (2) the plaintiff's bad faith in bringing the suit, (3) the unusually vexatious and oppressive manner in which it is prosecuted, or (4) perhaps for other reasons as well.” King v. PA Consulting Grp., Inc., 485 F.3d 577, 592 (10th Cir. 2007) (listing factors that could make a Lanham Act case exceptional); Derma Pen, 999 F.3d at 1245 (noting that court could affirm Lanham Act fee award under King or Octane because the “Octane standard applies to fee awards for exceptional cases under the Lanham Act”). Ultimately, a court considers the “objective strength of a plaintiffs [sic] Lanham Act claim and the plaintiff’s subjective motivations.” Id. at 1244. III. ANALYSIS3 A. Dawgs’s Antitrust Claims The Individual Defendants seek attorney’s fees for what they call “Dawgs’s patent-related antitrust claims.” Docket No. 1081 at 7–8. Federal Rule of Civil

Free access — add to your briefcase to read the full text and ask questions with AI

Crocs, Inc. v. Effervescent, Inc, (D. Colo. 2022).

Crocs, Inc. v. Effervescent, Inc (Crocs, Inc. v. Effervescent, Inc) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Dastar Corp. v. Twentieth Century Fox Film Corp.
539 U.S. 23 (Supreme Court, 2003)
United Phosphorus, Ltd. v. Midland Fumigant, Inc.
205 F.3d 1219 (Tenth Circuit, 2000)
United States v. Wooten
377 F.3d 1134 (Tenth Circuit, 2004)
Alfonse Reichenberger v. Rev. Richard Pritchard
660 F.2d 280 (Seventh Circuit, 1981)
General Steel Domestic Sales, LLC v. Chumley
627 F. App'x 682 (Tenth Circuit, 2015)
Lumen View Technology LLC v. Findthebest.com, Inc.
811 F.3d 479 (Federal Circuit, 2016)
Edward Lewis Tobinick, MD v. M.D. Steven NOvella
884 F.3d 1110 (Eleventh Circuit, 2018)
Xlear, Inc. v. Focus Nutrition, LLC
893 F.3d 1227 (Tenth Circuit, 2018)
LHO Chicago River, L.L.C. v. Joseph Perillo
942 F.3d 384 (Seventh Circuit, 2019)
Derma Pen v. 4EverYoung Limited
999 F.3d 1240 (Tenth Circuit, 2021)
Hardt v. Reliance Standard Life Insurance Co.
176 L. Ed. 2d 998 (Supreme Court, 2010)
United States v. Hardman
297 F.3d 1116 (Tenth Circuit, 2002)
Octane Fitness, LLC v. Icon Health
134 S. Ct. 1749 (Supreme Court, 2014)